Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2270677
Max Phase: Preclinical
Molecular Formula: C16H24N3O10PS2
Molecular Weight: 513.49
Molecule Type: Small molecule
Associated Items:
ID: ALA2270677
Max Phase: Preclinical
Molecular Formula: C16H24N3O10PS2
Molecular Weight: 513.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COP(=S)(NN1C(=O)CS/C1=N/[C@@H]1OC[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O)OC
Standard InChI: InChI=1S/C16H24N3O10PS2/c1-8(20)27-11-6-26-15(14(29-10(3)22)13(11)28-9(2)21)17-16-19(12(23)7-32-16)18-30(31,24-4)25-5/h11,13-15H,6-7H2,1-5H3,(H,18,31)/b17-16+/t11-,13+,14-,15-/m1/s1
Standard InChI Key: MXVVCHWUWKVTCN-WWBGHNHMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 513.49 | Molecular Weight (Monoisotopic): 513.0641 | AlogP: 0.09 | #Rotatable Bonds: 8 |
Polar Surface Area: 151.29 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 7.45 | CX Basic pKa: | CX LogP: -0.01 | CX LogD: -0.28 |
Aromatic Rings: 0 | Heavy Atoms: 32 | QED Weighted: 0.27 | Np Likeness Score: 0.39 |
1. Li YX, Wang HA, Yang XP, Cheng HY, Wang ZH, Li YM, Li ZM, Wang SH, Yan DW.. (2009) Regioselective synthesis of novel 3-alkoxy (phenyl) thiophosphorylamido-2-(per-O-acetylglycosyl-1'-imino)thiazolidine-4-one derivatives from O-alkyl N4-glycosyl(thiosemicarbazido)phosphonothioates., 344 (10): [PMID:19450796] [10.1016/j.carres.2009.03.027] |
Source(1):